100 Active Studies

Ankylosing Spondylitis Clinical Trials

Find actively recruiting research studies for ankylosing spondylitis. Connect with study sites near you and explore new treatment options.

100
Active Trials
271+
Locations
812,187
Participants Needed

Recruiting Studies

RecruitingNCT03944447

Outcomes Mandate National Integration With Cannabis as Medicine

This will be a multistate, multicenter clinical study to determine the efficacy and safety of medical cannabis for a wide variety of chronic medical conditions....

10 locations(Boca Raton, Bradenton, Fort Lauderdale)
200,000 participants
OMNI Medical Services, LLC
View Study Details
RecruitingNCT00785525

Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors

The purpose of the study is to: * Establish and evaluate a system for collection of filgrastim-mobilized peripheral blood stem cells from National Marrow Donor Program donors (NMDP) donors * Assess t...

4 locations(Boca Raton, Rockville, Minneapolis)
60,000 participants
Center for International Blood and Marrow Transplant Research
View Study Details
RecruitingNCT02735707

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform trial for community-acquired pneumonia. The purpose of this study is to evaluate the effect of a range of interventions to impro...

10 locations(Jacksonville, Augusta, Chicago)
20,000 participants
UMC Utrecht
View Study Details
RecruitingNCT04262206

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in com...

10 locations(Birmingham, Birmingham, Tucson)
20,000 participants
Duke University
View Study Details
RecruitingNCT06802224

The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery

Low blood pressure, also known as hypotension, is very common during major surgery under general anesthesia. Prolonged or severe hypotension can lead to complications such as kidney injury after surge...

2 locations(San Francisco, Ann Arbor)
18,000 participants
University of California, San Francisco
View Study Details
RecruitingNCT06292013

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart ...

10 locations(Birmingham, Daphne, Dothan)
16,700 participants
Eli Lilly and Company
View Study Details
RecruitingNCT05754957

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

The purpose of this study is to evaluate that milvexian is superior to placebo, in addition to standard-of-care, in reducing the risk of major adverse cardiovascular event (MACE) (the composite of car...

10 locations(Alexander City, Birmingham, Birmingham)
16,000 participants
Janssen Research & Development, LLC
View Study Details
RecruitingNCT07000357

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

The purpose of this phase 3, randomized, placebo controlled, event-driven study is to assess the effect of AZD0780, an oral PCSK9 inhibitor, compared with placebo in reducing the risk of MACE-PLUS in ...

10 locations(Birmingham, Fairhope, Foley)
15,100 participants
AstraZeneca
View Study Details
RecruitingNCT07177352

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies....

10 locations(Imperial, Inglewood, Irvine)
13,000 participants
Hoffmann-La Roche
View Study Details
RecruitingNCT07037433

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of care with respect to reducing cardiovascular (CV) morb...

10 locations(Daphne, Fairhope, Huntsville)
12,800 participants
Amgen
View Study Details
RecruitingNCT07064473

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. ...

10 locations(Anniston, Fairhope, Guntersville)
11,800 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT06677060

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Participants include men and women ≥ 40 years of age with T2DM, established CV disease, a history of HTN with an SBP of at least 130 mmHg at screening, who meet the predefined serum potassium level, a...

10 locations(Birmingham, Centreville, Fairhope)
11,300 participants
AstraZeneca
View Study Details
RecruitingNCT06531824

EASi-KIDNEYâ„¢ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study. The study is open to people who take other medicin...

10 locations(Huntsville, Surprise, Jacksonville Beach)
11,000 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT07136012

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarction, or urgent coronary revascularization...

10 locations(Alexander City, Daphne, Fairhope)
11,000 participants
Amgen
View Study Details
RecruitingNCT06468202

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

The overall goal of this large, pragmatic, comparative effectiveness trial is to test the hypothesis that among at-risk individuals, 162 mg/day aspirin is superior to 81 mg/day in preventing Hypertens...

10 locations(Los Angeles, San Francisco, Chicago)
10,742 participants
Ohio State University
View Study Details
RecruitingNCT07157774

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

The purpose of this study is to evaluate the efficacy of muvalaplin in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart a...

10 locations(Concord, Fountain Valley, Redding)
10,450 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06672055

A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

The primary objective of the study is to determine the relative efficacy of the investigational oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccine tablet VXA-CoV2-3.3 compared to...

10 locations(Anniston, Birmingham, Mobile)
10,400 participants
Vaxart
View Study Details
RecruitingNCT06534892

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

The purpose of this study is: * To investigate the optimal timing for revaccination after the initial RSVPreF3 OA vaccine dose, * To evaluate the long-term immune persistence and safety up to 5 conse...

10 locations(Birmingham, Birmingham, Huntsville)
10,353 participants
GlaxoSmithKline
View Study Details
RecruitingNCT06742281

A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults

The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID-19 Vaccine, mRNA; 2024-2025 Formula), a currently a...

10 locations(Anniston, Phoenix, Chula Vista)
10,016 participants
CyanVac LLC
View Study Details
RecruitingNCT06383390

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will e...

10 locations(Alabaster, Birmingham, Daphne)
10,000 participants
Eli Lilly and Company
View Study Details
RecruitingNCT06118281

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. Ziltivekimab might reduce development of heart disease, the...

10 locations(Alexander City, Birmingham, Birmingham)
10,000 participants
Novo Nordisk A/S
View Study Details
RecruitingNCT03851445

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to ...

10 locations(Birmingham, Mobile, Anchorage)
10,000 participants
SWOG Cancer Research Network
View Study Details
RecruitingNCT05986292

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

The purpose of the chronic pain master protocol is to compare independent pain interventions and establish an overarching structure for the disease-state addenda (DSA) and intervention-specific append...

10 locations(Birmingham, Birmingham, Glendale)
10,000 participants
Eli Lilly and Company
View Study Details
RecruitingNCT02000089

The Cancer of the Pancreas Screening-5 CAPS5)Study

Johns Hopkins clinical research office quality assurance group will monitor and audit this study at Johns Hopkins. The Sub Investigator at each site will be responsible for internal monitoring at thei...

9 locations(New Haven, Baltimore, Boston)
9,000 participants
Johns Hopkins University
View Study Details
RecruitingNCT06098079

Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)

A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB)....

10 locations(Birmingham, Cullman, Mobile)
8,600 participants
Currax Pharmaceuticals
View Study Details
RecruitingNCT06605118

Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial

This is a phase-III multi-center double-blind randomized controlled trial of 8,000 individuals undergoing a scheduled or prelabor cesarean delivery who are randomized to either adjunctive azithromycin...

10 locations(Birmingham, San Francisco, Chicago)
8,000 participants
The George Washington University Biostatistics Center
View Study Details
RecruitingNCT05514054

A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cancer that is estrogen receptor positive (ER+) and huma...

10 locations(Daphne, Huntsville, Mobile)
8,000 participants
Eli Lilly and Company
View Study Details
RecruitingNCT03848312

Preventing Alzheimer's With Cognitive Training

Dementia is the most expensive medical condition in the US and increases in prevalence with age. More than 5 million Americans have Alzheimer's disease, the most common form of dementia. Mild cognitiv...

7 locations(Gainesville, Jacksonville, Jacksonville)
7,600 participants
University of South Florida
View Study Details
RecruitingNCT02915198

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

This research will help us to learn if the medicine called metformin reduces the risk of death, heart attacks, and/or strokes in Veterans who have pre-diabetes and heart or blood vessel problems....

10 locations(Phoenix, Tucson, Little Rock)
7,410 participants
VA Office of Research and Development
View Study Details
RecruitingNCT05121324

Pediatric Dose Optimization for Seizures in Emergency Medical Services

The Pediatric Dose Optimization for Seizures in Emergency Medical Services (PediDOSE) study is designed to improve how paramedics treat seizures in children on ambulances. Seizures are one of the most...

10 locations(Tucson, Los Angeles, Sacramento)
6,000 participants
Stanford University
View Study Details
RecruitingNCT06424288

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more...

10 locations(Mobile, Mobile, Chula Vista)
6,000 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT05390892

PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes

PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients...

8 locations(Baltimore, Duluth, Columbia)
6,000 participants
Brigham and Women's Hospital
View Study Details
RecruitingNCT06909565

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

V-INTERVENTION will evaluate the effectiveness of inclisiran in preventing major cardiovascular and limb events in patients receiving percutaneous coronary or peripheral arterial revascularization. In...

5 locations(Beverly Hills, Newport Beach, Bridgewater)
6,000 participants
Duke University
View Study Details
RecruitingNCT07160244

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

BEATRIX (group B strEptococcus mATeRnal and Infant VaX study) The purpose of this study is to learn about the safety and how the group B streptococcus (GBS) vaccine works in pregnant women and their b...

10 locations(Idaho Falls, Idaho Falls, Idaho Falls)
6,000 participants
Pfizer
View Study Details
RecruitingNCT05636176

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get ziltivekimab or placebo. Participants will get study...

10 locations(Alexander City, Fairhope, Huntsville)
5,600 participants
Novo Nordisk A/S
View Study Details
RecruitingNCT05952557

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

This is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard adjuvant endocrine therapy for patients with ER+/HER2- early breast cancer with intermediate-high ...

10 locations(Dothan, Phoenix, Tucson)
5,500 participants
AstraZeneca
View Study Details
RecruitingNCT06084234

National Liver Cancer Screening Trial

The National Liver Cancer Screening Trial is an adaptive randomized phase IV Trial comparing ultrasound-based versus biomarker-based screening in 5500 patients with cirrhosis from any etiology or pati...

10 locations(Los Angeles, Redwood City, Roseville)
5,500 participants
University of Texas Southwestern Medical Center
View Study Details
RecruitingNCT07037459

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

This study will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascu...

10 locations(Dothan, Fairhope, Huntsville)
5,056 participants
Amgen
View Study Details
RecruitingNCT01042379

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

The purpose of this study is to further advance the ability to practice personalized medicine by learning which new drug agents are most effective with which types of breast cancer tumors and by learn...

10 locations(Birmingham, Scottsdale, Tucson)
5,000 participants
QuantumLeap Healthcare Collaborative
View Study Details
RecruitingNCT06283966

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

This study will evaluate the effect of triple ICS/LAMA/LABA therapy with BGF MDI 320/14.4/9.6 μg on cardiopulmonary outcomes relative to LAMA/LABA therapy with GFF MDI 14.4/9.6 μg in a population with...

10 locations(Athens, Cullman, Fairhope)
5,000 participants
AstraZeneca
View Study Details
RecruitingNCT06742723

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

International, Multicenter, Double-Blind, Placebo-Controlled and Event-driven study to assess efficacy, safety and Tolerability of Baxdrostat in combination with Dapagliflozin on renal outcomes and ca...

10 locations(Fairhope, Surprise, Tucson)
5,000 participants
AstraZeneca
View Study Details
RecruitingNCT03959085

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial al...

10 locations(Birmingham, Mobile, Anchorage)
4,997 participants
Children's Oncology Group
View Study Details
RecruitingNCT06307652

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients with chronic HF and impaired kidney function...

10 locations(Alexander City, Birmingham, Fairhope)
4,800 participants
AstraZeneca
View Study Details
RecruitingNCT06702878

Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

This is a Phase 3 multi-center, group-randomized, crossover trial to compare nasal antimicrobial photodisinfection therapy (aPDT) with standard of care for prevention of surgical site infections in pa...

10 locations(Englewood, Brandon, Largo)
4,514 participants
Ondine Biomedical Inc.
View Study Details
RecruitingNCT07104500

VK2735 for Weight Management Phase 3

This is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic ef...

10 locations(Birmingham, Birmingham, Huntsville)
4,500 participants
Viking Therapeutics, Inc.
View Study Details
RecruitingNCT07044297

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

Researchers are looking for new medicines to prevent HIV-1 (Human Immunodeficiency Virus Type 1) infection. The goals of this study are to learn: * If taking MK-8527 once a month works to prevent HI...

10 locations(Birmingham, Los Angeles, San Francisco)
4,390 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT05774951

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

This is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard endocrine therapy in patients with ER+/HER2 - early breast cancer with intermediate or high risk f...

10 locations(Birmingham, Dothan, Anchorage)
4,300 participants
AstraZeneca
View Study Details
RecruitingNCT05543616

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

The purpose of this clinical trial is to learn about the safety, extent of the side effects, and immune responses of the study vaccine (called variant-adapted BNT162b2 RNA-based vaccine) in healthy ch...

10 locations(Birmingham, Birmingham, Phoenix)
4,292 participants
BioNTech SE
View Study Details
RecruitingNCT06492616

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal G...

10 locations(Daphne, Chandler, Gilbert)
4,220 participants
Stemline Therapeutics, Inc.
View Study Details
RecruitingNCT06935370

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People can join the study if they have been diagnosed with c...

10 locations(Mobile, Montgomery, Beverly Hills)
4,200 participants
Boehringer Ingelheim
View Study Details
RecruitingNCT02693535

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or ...

10 locations(Birmingham, Phoenix, Auburn)
4,200 participants
American Society of Clinical Oncology
View Study Details
RecruitingNCT04636814

A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)

The purpose of this study is to evaluate the efficacy and the safety of two doses of CHF6001 (Tanimilast) as add-on to maintenance triple therapy in the target patient population....

10 locations(Andalusia, Foley, Guntersville)
3,980 participants
Chiesi Farmaceutici S.p.A.
View Study Details
RecruitingNCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast ...

10 locations(Birmingham, Anchorage, Anchorage)
3,960 participants
NRG Oncology
View Study Details
RecruitingNCT06076304

Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Sinusitis

Sinus infections are sometimes treated with oral antibiotics or nasal steroid sprays, while some patients get better on their own. Some patients may wait a few days or use common over-the-counter reme...

7 locations(Los Angeles, Washington D.C., Hyattsville)
3,720 participants
Daniel Merenstein
View Study Details
RecruitingNCT06058377

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-I...

10 locations(Birmingham, Anchorage, Tucson)
3,680 participants
National Cancer Institute (NCI)
View Study Details
RecruitingNCT03486873

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based parent studies who transition into this ex...

10 locations(Tucson, Bakersfield, Fresno)
3,500 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT03474029

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

This study is conducted to compare the safety and effectiveness of a novel short 6-week regimen of daily rifapentine (6wP, experimental arm) with a comparator arm of 12-16 weeks of rifamycin-based tre...

10 locations(Denver, Washington D.C., Washington D.C.)
3,400 participants
Centers for Disease Control and Prevention
View Study Details
RecruitingNCT04045665

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet t...

10 locations(Little Rock, Los Angeles, Los Angeles)
3,200 participants
Icahn School of Medicine at Mount Sinai
View Study Details
RecruitingNCT06667700

A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most often causes mild flu or cold-like symptoms. However, people with certain health condition...

10 locations(Cullman, Paradise Valley, Phoenix)
3,082 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT07116967

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis...

10 locations(Birmingham, Phoenix, Phoenix)
3,040 participants
Bristol-Myers Squibb
View Study Details
RecruitingNCT05026866

A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD). Approximately 800 additional participants will be enrolled...

10 locations(Birmingham, Homewood, Huntsville)
2,996 participants
Eli Lilly and Company
View Study Details
RecruitingNCT05564377

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nea...

10 locations(Birmingham, Mobile, Anchorage)
2,900 participants
National Cancer Institute (NCI)
View Study Details
RecruitingNCT05624450

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental oxygen, on the prevention of death or progression t...

10 locations(Mobile, Phoenix, Phoenix)
2,870 participants
AstraZeneca
View Study Details
RecruitingNCT06345339

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

This study will evaluate the efficacy and safety of Armour Thyroid treatment compared with synthetic T4 in subjects who have primary hypothyroidism and are currently stabilized (i.e., in-range thyroid...

10 locations(Birmingham, Birmingham, Bonita)
2,800 participants
AbbVie
View Study Details
RecruitingNCT05443737

Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients

The purpose of this study is to evaluate the effectiveness of a multi-component intervention to improve young cancer survivors' engagement in goal-concordant oncofertility care, concurrently with obse...

4 locations(Duarte, El Centro, La Jolla)
2,800 participants
University of California, San Diego
View Study Details
RecruitingNCT07000123

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event

This is a study to evaluate the efficacy and safety of AZD0780 in adults with clinical ASCVD or who are at risk for a first ASCVD event and who have elevated LDL-C. AZD0780 is a small molecule that re...

10 locations(Huntsville, Irondale, Mobile)
2,800 participants
AstraZeneca
View Study Details
RecruitingNCT06433635

Sequential Multiple Assignment Randomized Trial for Bipolar Depression

This is a sequential multiple assignment randomized trial for adults (ages \> 18) with a bipolar disorder type 1 diagnosis currently experiencing a depressive episode. It is a randomized pragmatic tri...

10 locations(Birmingham, Bloomington, Baltimore)
2,726 participants
Massachusetts General Hospital
View Study Details
RecruitingNCT05586776

Decolonization to Reduce After-Surgery Events of Surgical Site Infection

The DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site Infection) is a two-arm multi-center individual placebo-controlled randomized (2,700 participants randomized 1:1)...

4 locations(Newport Beach, Orange, Sacramento)
2,700 participants
University of California, Irvine
View Study Details
RecruitingNCT06821061

A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People

The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together. This study is seeking healthy participants aged 18 or older. All participants i...

10 locations(Anaheim, Lake Forest, Riverside)
2,645 participants
BioNTech SE
View Study Details
RecruitingNCT05931276

CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes

The investigators aim to determine, using a point-of-care randomized controlled trial design, if hemodialysis patients, who are randomized to metoprolol succinate (a dialyzable, beta-1 selective beta ...

3 locations(Boston, Minneapolis, New York)
2,540 participants
VA Office of Research and Development
View Study Details
RecruitingNCT03625648

Pentoxifylline in Diabetic Kidney Disease

Pentoxifylline (PTX) is a medication that has been on the market since 1984 for use in disease in the blood vessels of the legs. There is some preliminary information that it may protect the kidneys f...

10 locations(Phoenix, Little Rock, Loma Linda)
2,510 participants
VA Office of Research and Development
View Study Details
RecruitingNCT06268873

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

The purpose of this study is to measure the efficacy and safety of baxdrostat/dapagliflozin in participants ≥ 18 years of age with CKD and HTN. This study consists of a screening, a 4-week dapagliflo...

10 locations(Fairhope, Phoenix, Surprise)
2,500 participants
AstraZeneca
View Study Details
RecruitingNCT06372145

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

This is a Phase 3 extension, global, multicenter study to assess the long-term safety and tolerability of tolebrutinib in adult participants (aged ≥18 years) with RMS, PPMS, or NRSPMS who were previou...

10 locations(Birmingham, Cullman, Phoenix)
2,500 participants
Sanofi
View Study Details
RecruitingNCT04606264

Recommendations of Enhanced Recovery Interventions for Patient's Clinical Team and Collection of Associated Data

This REMAP Periop ERP domain study falls under the Periop Core Protocol, which compares the different recommended strategies for enhancing recovery through the use of various standard of care treatmen...

3 locations(Pittsburgh, Pittsburgh, Pittsburgh)
2,500 participants
Jennifer Holder-Murray
View Study Details
RecruitingNCT05929768

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast canc...

10 locations(Anchorage, Anchorage, Anchorage)
2,400 participants
SWOG Cancer Research Network
View Study Details
RecruitingNCT06966700

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Researchers are looking for new ways to treat types of breast cancer that are both: * High-risk, which means the cancer may have a higher chance of getting worse or coming back after treatment * Earl...

10 locations(Fullerton, Denver, Grand Junction)
2,400 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingNCT06679140

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do not need to be in the hospital but who are at high risk for progressio...

10 locations(Little Rock, Bakersfield, Inglewood)
2,330 participants
Pfizer
View Study Details
RecruitingNCT06824194

Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

This study is a Phase 3, randomized, modified double-blind study which aims to document the safety profile of the PCV21 vaccine (investigational pneumococcal vaccine) compared to a licensed 20-valent ...

10 locations(Guntersville, Jonesboro, Concord)
2,320 participants
Sanofi
View Study Details
RecruitingNCT05485961

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis

This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a dose-finding study for CSL300 vs placebo. Part 2 (pha...

10 locations(Huntsville, Montgomery, Glendale)
2,310 participants
CSL Behring
View Study Details
RecruitingNCT03968393

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Perioperative AF After Noncardiac Surgery

Multinational, investigator-initiated study of oral anticoagulation versus no anticoagulation for the prevention of stroke and other adverse cardiovascular events in patients with transient perioperat...

10 locations(Los Angeles, Houston, Coronel Suárez)
2,270 participants
Population Health Research Institute
View Study Details
RecruitingNCT05882877

A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD....

10 locations(Birmingham, Phoenix, Phoenix)
2,200 participants
Amgen
View Study Details
RecruitingNCT06520826

Vafseo Outcomes In-Center Experience

This trial is an investigator-initiated, multi-center, randomized (1:1), open-label, active-controlled, pragmatic study of the safety of vadadustat administered three times per week for the treatment ...

5 locations(Lone Tree, Dalton, Gallup)
2,200 participants
USRC Kidney Research
View Study Details
RecruitingNCT06052267

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

The primary objective of the study is to assess the efficacy of high dose and low dose fluticasone propionate (Fp)/albuterol sulfate (ABS) integrated electronic module multidose dry powder inhaler (eM...

10 locations(Birmingham, Dothan, Paradise Valley)
2,196 participants
Teva Branded Pharmaceutical Products R&D, Inc.
View Study Details
RecruitingNCT03488693

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers w...

10 locations(Fairbanks, Tucson, Tucson)
2,140 participants
Canadian Cancer Trials Group
View Study Details
RecruitingNCT04373564

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

This study is a postmarketing requirement jointly carried out by four NDA holders (Bayer AG, Bracco, GE Healthcare and Guerbet) and the CRO IQVIA. The study aims to create detailed images of the orga...

10 locations(Scottsdale, New Haven, Chicago)
2,076 participants
Guerbet
View Study Details
RecruitingNCT05050084

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

This phase III trial uses the Decipher risk score to guide therapy selection. Decipher score is based on the activity of 22 genes in prostate tumor and may predict how likely it is for recurrent prost...

10 locations(Birmingham, Gilbert, Gilbert)
2,050 participants
NRG Oncology
View Study Details
RecruitingNCT05918861

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

This is a placebo-controlled, randomized, double-blind, parallel group, phase 3 multicenter study in subjects recently hospitalized for ACS and with the appropriate genetic profile. Subjects will prov...

10 locations(Alexander City, Birmingham, Fairhope)
2,000 participants
DalCor Pharmaceuticals
View Study Details
RecruitingNCT04453293

Immunization With BCG Vaccine to Prevent Tuberculosis Infection

The purpose of this research is to find out if a single dose of pre-travel vaccination with BCG can lessen tuberculosis (TB) infection by producing an immune response when given to adults traveling to...

7 locations(New Haven, Washington D.C., Decatur)
2,000 participants
Henry M. Jackson Foundation for the Advancement of Military Medicine
View Study Details
RecruitingNCT06422689

Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care

ANCHOR is a prospective, multi-center, phase IV, interventional, single-arm, open-label study of 2,000 adult participants with symptomatic asthma requiring the use of rescue therapy aimed to compare t...

6 locations(Boston, Springfield, Ann Arbor)
2,000 participants
AstraZeneca
View Study Details
RecruitingNCT05564390

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific laboratory tests to help improve participants' ability to register to clinical tria...

10 locations(Birmingham, Phoenix, Tucson)
2,000 participants
National Cancer Institute (NCI)
View Study Details
RecruitingNCT02901184

Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction

Heart failure with preserved ejection fraction (HFPEF) is common and deadly but without therapy. Inconclusive studies such as TOPCAT (Treatment of Preserved Cardiac Function Heart Failure With an Aldo...

10 locations(Alexander City, Birmingham, Tucson)
2,000 participants
Uppsala University
View Study Details
RecruitingNCT03013998

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

This screening and multi-sub-study Phase 1b/2 trial will establish a method for genomic screening followed by assigning and accruing simultaneously to a multi-study "Master Protocol (BAML-16-001-M1)."...

10 locations(Phoenix, Los Angeles, San Francisco)
2,000 participants
Beat AML, LLC
View Study Details
RecruitingNCT07015905

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

This study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim...

4 locations(Englewood, Sarasota, Tamarac)
2,000 participants
Regeneron Pharmaceuticals
View Study Details
RecruitingNCT05878769

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) who have completed the 52-week ...

10 locations(Birmingham, Dothan, Jasper)
2,000 participants
Hoffmann-La Roche
View Study Details
RecruitingNCT06964464

Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator

This prospective, multicenter, open-label, randomized comparative effectiveness trial, titled CARVTOP-ICD, evaluates the impact of carvedilol versus metoprolol succinate in patients with heart failure...

10 locations(Scottsdale, Rome, Shawnee Mission)
2,000 participants
University of Rochester
View Study Details
RecruitingNCT05763602

PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)

The purpose of this study is to see whether applying povidone iodine (PVI) to the noses of patients undergoing lower extremity (leg, ankle, or foot) orthopedic fixation procedures of high-energy lower...

6 locations(Atlanta, Indianapolis, Iowa City)
2,000 participants
Loreen Herwaldt
View Study Details
RecruitingNCT06550076

A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

The main aim of this study is to check the side effects of TAK-279 and how well it is tolerated in participants with moderate-to-severe plaque psoriasis. All participants will be assigned to study tr...

10 locations(Birmingham, Birmingham, Hoover)
1,950 participants
Takeda
View Study Details
RecruitingNCT05174169

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer....

10 locations(Birmingham, Fairhope, Mobile)
1,912 participants
NRG Oncology
View Study Details
RecruitingNCT05675410

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

This phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and nivolumab) to standard treatment (chemotherapy with or without radiation) to the standard treatment alone in i...

10 locations(Birmingham, Mobile, Anchorage)
1,875 participants
National Cancer Institute (NCI)
View Study Details
RecruitingNCT05742802

Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).

Subjects who completed either OBERON or TITANIA will be offered the opportunity to consent for this Multicentre, Double-blind, Randomised, Placebo controlled, Parallel Group, Phase 3, extension study ...

10 locations(Huntsville, Sheffield, Tempe)
1,869 participants
AstraZeneca
View Study Details

Frequently Asked Questions

What clinical trials are available for Ankylosing Spondylitis?

There are currently 100 actively recruiting clinical trials for ankylosing spondylitis. These studies are testing new treatments, therapies, and interventions at research sites across 271 cities.

How do I join a Ankylosing Spondylitis clinical trial?

To join a ankylosing spondylitis clinical trial: 1) Browse the available studies above, 2) Click on a study that interests you, 3) Complete the eligibility form, and 4) A study coordinator will contact you.

Are clinical trials free for patients?

Yes, clinical trial participation is free. In most studies, the treatment, medical tests, and doctor visits related to the trial are provided at no cost. Some studies may also compensate for time and travel.

Can I leave a clinical trial if I change my mind?

Yes, participation in any clinical trial is completely voluntary. You can withdraw at any time, for any reason, without affecting your regular medical care.